The effect of hypoxia on endothelium-dependent and endothelium-independent vasodilation was studied in phenylephrine-precontracted, isolated rings of rabbit first-branch pulmonary artery. Concentration-dependent relaxation responses to the endothelium-dependent dilators methacholine, ATP, and the calcium ionophore (A23187) as well as to the endothelium-independent dilators sodium nitroprusside and isoproterenol were obtained before, during, and after exposure to hypoxia (POj=42±l mm Hg) in the presence of indomethacin (2.8 xKT* M). This moderate degree of hypoxia inhibited (p<0.05) endothelium-dependent but not endotheliumindependent relaxation responses without producing irreversible vascular damage. In parallel experiments, cyclic GMP accumulation in pulmonary vascular rings in response to maximal doses of the above vasodilators was measured in the presence and absence of hypoxia. Cyclic GMP accumulation in response to endothelium-dependent dilators (methacholine, ATP, and A23187) was inhibited (p<0.05) by hypoxia while cyclic GMP accumulation in response to the endothelium-independent dilator sodium nitroprusside was not. When phenylephrine precontracted vessels were exposed to hypoxia in the absence of vasodilators, a small, transient increase in tension occurred, which was greater in endothelium-intact than hi endotheliumdenuded vessels ( 
discovery that numerous endogenous and exogenous vasodilators require an intact endothelium to exert their relaxing effects on vascular smooth muscle. This was first reported in 1980 by Furchgott and Zawadzki, 1 who showed that the relaxation of strips of rabbit thoracic aorta by acetylcholine required an intact endothelium. A substance termed "endothelium-derived relaxing factor" (EDRF) was shown to be produced by the endothelium in response to acetylcholine and to be released and transferred to the vascular smooth muscle. Subsequently, several other substances have been found to produce vascular relaxation either partially or completely by endotheliumdependent mechanisms.
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1509 relaxation in the pulmonary circulation. It has been shown that several agents, including acetylcholine, histamine, arachidonic acid, ATP, and the calcium ionophore A23187, cause endothelium-dependent relaxations of isolated rabbit pulmonary arteries. EDRF released from the pulmonary endothelial cell can be transferred to vascular smooth muscle, where it causes relaxation. The production or release of EDRF by pulmonary endothelial cells is preceded or accompanied by an increase in endothelial cell intracellular calcium. 1516 EDRF-mcdiated relaxation of pulmonary vascular smooth muscle can be correlated with an activation of guanylate cyclase and an increase in the tissue content of cyclic GMP. The sensitivity of endothelium-dependent responses to changes in oxygen tension in systemic vessels has been known since EDRF was described initially in 1980.
] Endothelium-dependent relaxation responses to acetylcholine and thrombin were abolished reversibly under anoxic conditions, and the response to ATP was reduced. 17 - 18 It is possible that the normal low vascular resistance of the pulmonary circulation is dependent on the presence of an endothelium-derived relaxing factor. Several substances that cause pulmonary vasodilation under conditions of increased pulmonary vascular tone also cause endothelium-dependent relaxation of isolated arteries. These include bradykinin, histamine, substance P, vasoactive intestinal peptide, and acetylcholine. A reduction in either the release of or vascular response to EDRF during hypoxia could contribute to hypoxia-induced pulmonary vasoconstriction or pulmonary hypertension associated with pulmonary diseases such as the adult respiratory distress syndrome. The objective of this study was to determine if the relaxation of pulmonary arteries by endothelium-dependent and/ or independent vasodilators is impaired by hypoxia and to investigate the site or sites at which hypoxia might enhance vascular tone.
Materials and Methods

Vessel Preparation and Conditions of Hypoxia
New Zealand White rabbits (2.1 kg) were anesthetized with ketamine and killed by aortic exsanguination in accordance with our institutional animal care committee guidelines. The heart and lungs were removed and placed in cold Krebs' solution (NaCI 111 mM, KC1 5 mM, NaH 2 PO 4 1 mM, MgCl 2 0.5 mM, NaHCO 3 25 mM, CaCl 2 2.5 mM, dextrose 11.1 mM). The right and left first branches of the pulmonary artery were then carefully dissected free of perihilar fat and extraneous tissue and cut into 2.5-mm rings. In some rings, the endothelium was removed by rotating the ring gently on the tip of a forceps. The rings were then mounted in waterjacketed baths containing Krebs' buffer at 37° C, gassed with 95% air-5% CO 2 and connected to force transducers (model FT-03, Grass Instruments, Quincy, Massachusetts) to measure isometric tension. Optimal resting tension was determined by preliminary length-tension experiments, and the rings were equilibrated at that tension until they stabilized (approximately 1.5 hours), with the bath fluid being changed every 15-20 minutes. Active tension was induced with an EQo concentration of phenylephrine (7.25±1.34xlCT 7 M). The integrity of the endothelium of each ring studied was confirmed by observing its vascular response to methacholine (lxlfr* M). For studies of endotheliumintact vessels, if relaxation with methacholine was not 30% or greater, the ring was discarded. For studies of endothelium-denuded vessels, the rings were discarded if there was any degree of relaxation. In randomly selected rings, the status of the endothelium also was confirmed by scanning electron microscopy. Hypoxia was produced by gassing the baths with a blend of 95% nitrogen-5% CO 2 and 95% air-5% CO 2 . The Po 2 of the Krebs' solution in the tissue baths was determined with a blood gas analyzer (Radiometer America, Westlake, Ohio) during each cycle of each experiment. The mean dissolved partial pressure of oxygen in the bath fluid during normoxia cycles was 136 ±2 mm Hg and during hypoxia, 42±1 mm Hg. This level of Po 2 for hypoxia was chosen after extensive preliminary experiments. At lower Po 2 values (30 mm Hg or less), vessels did not respond to contractile or relaxing agents appropriately or consistently in subsequent control normoxia cycles, implying permanent tissue damage. At higher Po 2 values (50 mm Hg and above), there was no significant inhibition of endothelium-dependent relaxation responses. Unless otherwise noted, indomethacin (2.8xlO~5 M) was present in the buffer throughout all experiments to eliminate relaxation responses due to prostacyclin. To eliminate the endothelium-independent relaxation responses due to the metabolism of ATP to adenosine (a direct acting vasodilator), experiments involving ATP were performed in the presence and absence of the potent adenosine receptor antagonist BW-A1443U at a concentration (lxlO" 5 M) that produces little or no inhibition of cycle AMP phosphodiesterase. 
Hypoxia and Agonist-Induced Vascular Relaxation
Cumulative concentration-dependent relaxation responses to the receptor-mediated, endotheliumdependent vasodilators methacholine (lxlO" 8 to lxlO" 5 M) and ATP (lxlO" 7 to 3xKT 5 M), the non-receptor-mediated endothelium-dependent dilator A23187 a calcium ionophore (3xlO~9 to 3xlO" 7 M), as well as to the endothelium-independent dilators sodium nitroprusside (1x10"'° to 3xlO" 7 M) and isoproterenol (1 xlO" 10 to 1 x 10 7 M) were determined before, during, and after exposure to hypoxia. Each ring served as its own control, and data were discarded if relaxation responses after hypoxia were not within 10% of those responses obtained before hypoxia No 6, December 1989 or if contractile responses during the hypoxia cycle were not within 15% of those during normoxia. Additional phenylephrine was required to achieve equivalent contraction during hypoxia cycles (mean phenylephrine concentration was 7.25±1.34xl0~7 M during normoxia and 4.42±4.02xl0~6 M during hypoxia).
Basal Effects of Hypoxia
In another set of experiments, the effects of hypoxia alone (no vasodilators) on the isometric tension of phenylephrine precontracted pulmonary vascular rings was studied. After preparation, equilibration, and determination of endothelial status as described above, endothelium-intact and denuded rings were precontracted with phenylephrine and then exposed to hypoxia for 20 minutes followed by immediate return to normoxia. The rings were then washed with buffer until they returned to baseline tension (45 minutes). One of several compounds was then added to the bath, and the cycle was repeated. The effects of the following putative inhibitors were evaluated: indomethacin (2.8xlO" 5 M), hemoglobin (lxlO^6 M), methylene blue (lxlO" 7 M), hydroquinone (lxlO" 6 M), and nordihydroguaiaretic acid (NDGA; lxlO" 6 M).
Hypoxia and Cyclic GMP
In parallel experiments, the effects of identical conditions of hypoxia on cyclic GMP concentrations under basal conditions and during the addition of various drugs to pulmonary vascular rings were determined. Vessels were prepared and equilibrated as described above. After precontraction with phenylephrine, the rings were stimulated with methacholine (lxlCT* M), ATP (lxlO" 5 M), A23187 (lxlCT 7 M), sodium nitroprusside (lxlCT 6 M), or isoproterenol (lxlO" 7 M) for 30 seconds at which time they were flash frozen by immersion in dry ice-cooled acetone and stored at -90° C for subsequent cyclic GMP and protein determinations.
Cyclic GMP was extracted by homogenizing the frozen rings in 2 ml iced IN H O , centrifuging at 1,000# for 10 minutes, lyophylizing the supernatant, and resuspending in 250 ^,1 of 0.1N HC1 for cyclic GMP radioimmunoassay as previously described. 20 The pellet was resuspended in 2 ml of 2N NaOH, incubated at 60° C until dissolved (approximately 1 hour), and assayed for protein by the method of Lowry.
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Data Analysis
Significant differences between vascular isometric tension responses during normoxia versus hypoxia were determined by the Student's paired t test. Statistical differences between hypoxiainduced changes in isometric tension in endotheliumintact and denuded vessels in the presence or absence of various inhibitors, and in hypoxiainduced changes in cyclic GMP content were performed using two-way analysis of variance followed by Newman-Keul's means comparison testing when appropriate. Data are expressed as mean±SEM and p<0.05 was accepted as significant. Each data point represents the mean of responses observed in vascular rings from seven to 10 animals unless otherwise noted.
Drugs and Chemicals
Methacholine, A23187, ATP, sodium nitroprusside, isoproterenol, hemoglobin, methylene blue, hydroquinone, NDGA, and indomethacin were obtained from Sigma Chemical Company, St. Louis, Missouri. NDGA and A23187 were prepared in dimethyl sulfoxide and diluted in buffer immediately before use. Indomethacin was dissolved in NaHCO 3 (150 mM; pH 8.8) and buffered to pH 7.4 with 2N HC1 before use. All other drugs were prepared in buffer on the day of use and kept on ice. BW-A1443U was a gift from Dr. Susan Daluge of the Burroughs-Wellcome Co, Research Triangle Park, North Carolina. Drugs were added at 100 times their final bath concentration. Dimethyl sulfoxide concentration did not exceed 0.01% and had no effect on vascular responses.
Results
Hypoxia significantly reduced the endotheliumdependent relaxation responses to both receptormediated (methacholine and ATP) and nonreceptor-mediated (A23187) endothelium-dependent dilators. Methacholine-induced relaxation ( Figure  1 ) was significantly inhibited (p<0.05) at concentrations ranging from lxlO" 7 to lxlO" 5 M. Relaxation to ATP (Figure 2 ) was significantly inhibited (p<0.05) at concentrations ranging from 3xl0" 6 to 3xlO~5 M and A23187-induced relaxation ( Figure 3 ) was significantly inhibited (p<0.05) from 1X10" 8 to 3x10 M). In contrast, relaxation in response to sodium nitroprusside (lxlO~1 0 to 3xl0" 7 M; Figure  4 ) a directly acting, non-endothelium-dependent vasodilator that, like EDRF, also activates vascular smooth muscle soluble guanylate cyclase and increases muscle cycle GMP levels, 23 -8 was not significantly impaired by identical conditions of hypoxia. Similarly, the relaxation responses to isoproterenol (lxlO" 10 to lxlO" 7 M; Figure 5 ), another directly acting, endothelium-independent vasodilator, which acts via cyclic AMP rather than cyclic GMP, also was not affected by hypoxia. Figure 6 demonstrates a typical response of phenylephrine-precontracted rabbit pulmonary artery rings with and without endothelium to hypoxia alone. The results of several of these experiments performed in the presence and absence of a variety of inhibitors of EDRF and of arachidonate metabolism are summarized in Tables 1 and 2 . On exposure to hypoxia, a transient constriction (0.70±0.12 g) followed by dilation was consistently observed in endothelium-intact rings. On return to normoxia, a transient dilation (0.68±0.29 g) was followed by the return to baseline phenylephrine-induced tension. In rings without endothelium, the hypoxia-induced transient constriction was reduced markedly (0.09±0.03 g; /xO.OOl) with no contractile response at all in seven of 18 rings from 10 animals. The transient dilation observed in denuded rings on return to normoxia was somewhat, but not significantly, reduced compared with intact rings (0.36±0.22 g). In intact rings, the contractile response to hypoxia was attenuated by preincubation with the known inhibitors of EDRF (Table 1) 
FIGURE 6. Transient effects of changes in oxygen tension on isometric tension development of rabbit pulmonary arteries. Representative isometric force tracings of endothelium-intact and denuded phenylephrine (PE) precontracted first branch pulmonary artery rings exposed to hypaxia and subsequently returned to normoxic conditions are shown. Indomethacin (2.8xlO~5 M) was present to inhibit cyclooxygenase and prevent the formation of prostaglandins and thromboxane. Methacholine was added after return to normoxia to confirm the status of the endothelium and to demonstrate that the endotheliumdependent relaxation response was not permanently altered by hypoxia.
EDRF at this concentration 22 -23 ) was present in the buffer. None of the inhibitors had a significant effect on the small contractile response observed in the endothelium-denuded vessels (Table 1) or on the transient dilation observed in intact and denuded vessels on return to normoxia ( Table 2) .
The inhibitory effects of hypoxia on endotheliumdependent increases in cyclic GMP content of pulmonary vascular rings were also examined. Consistent with the inhibitory effects on endotheliumdependent vascular relaxation (Table 3) , hypoxia significantly inhibited basal cyclic GMP content (/><0.05) as well as cyclic GMP content in response to the endothelium-dependent dilators methacholine (/?<0.05), ATP (/><0.05), and A23187 (/?<0.05). Hypoxia had no significant effect on the cyclic GMP content induced by the nonendothelium-dependent, directly acting dilator sodium nitroprusside.
Discussion
This study demonstrates that moderate hypoxia (Po 2 =42±l mm Hg) selectively and dramatically inhibits agonist-stimulated endothelium-dependent vasodilation as well as basal EDRF release in the isolated rabbit first-branch pulmonary artery. Concentration-dependent vasodilation responses produced by the endothelium-dependent vasodilators methacholine, ATP, and A23187 were significantly reduced by hypoxia, while responses to the endothelium-independent vasodilators sodium nitroprusside and isoproterenol were not changed. Parallel results were obtained when cyclic GMP accumulation in the vascular rings was used as the assay for EDRF.
Based on the known pharmacology of the vasodilating agonists used, the data provide information regarding the site at which hypoxia is likely to inhibit endothelium-dependent vasodilation. Because the actions of the non-receptor-mediated endotheliumdependent dilator A23187 were blocked to the same or greater degree as those of the receptor-mediated endothelium-dependent dilators methacholine and ATP, it is likely that hypoxia exerts an effect distal to the point of receptor activation at the endothelial cell. Also, sodium nitroprusside, an endotheliumindependent vasodilator, was not affected by hypoxia. Because both nitroprusside and EDRF exert effects on vascular smooth muscle via the activation of soluble guanylate cyclase resulting in an increase in intracellular cyclic GMP levels, this would imply that the site at which hypoxia inhibits endothelium-dependent vasodilation must be proximal to guanylate cyclase activation. The relaxation responses to isoproterenol also were not affected by hypoxia, suggesting that )3-adrenoceptor activation of adenylate cyclase is not sensitive to the levels of hypoxia used in this study.
The specific site and mechanism by which hypoxia inhibits EDRF is not clear. It is unlikely that this would be due to an effect on EDRF once produced. In fact, it has been shown that high oxygen tension destroys EDRF, probably as a result of generating the superoxide radical.
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- 25 Indeed, if EDRF is nitric oxide or a similar nitrogen-based radical species, as suggested by numerous recent studies, 26 -28 one would expect it to react with oxygen to form a more stable, nonradical species incapable of activating guanylate cyclase. The nitric oxide radical actually would be expected to have a longer half-life in a hypoxic or anoxic medium and thus be degraded more slowly than in a nonnoxic medium. It is thus more likely that hypoxia interferes with the production of EDRF. Griffith et al 29 have demonstrated that the production or release of EDRF was abolished by inhibitors of mitochondrial respiration, which would provide a potential mechanism by which anoxia/hypoxia may impair EDRF production. Further understanding of the mechanism of hypoxia-induced inhibition of EDRF, however, must await a more specific understanding of the metabolic pathway for EDRF synthesis.
Hypoxia alone caused a small, transient vasoconstriction in the isolated pulmonary artery model used in the current studies. Weir 30 has pointed out that hypoxia-induced vasoconstriction in the pulmonary circulation could be due to either the production of a constrictor or the inhibition of a tonic dilator. To determine if the observed vasoconstriction was in part due to 1) hypoxia-induced inhibition of a basally released EDRF, 2) inhibition of a dilating eicosanoid, or 3) production of a constricting eicosanoid from the endothelium, the hypoxiainduced contractile response was studied in the presence of a variety of inhibitors of EDRF and of arachidonate metabolism. In the present study, when the rings were preincubated with inhibitors of EDRF (hemoglobin, methylene blue, and hydroquinone), the hypoxia-induced contraction was markedly decreased, implying that a major component of the contractile response induced by hypoxia was due to the inhibition of basally released EDRF. Inhibitors of arachidonate metabolism (indomethacin, an inhibitor of cyclooxygenase, 31 and NDGA, an inhibitor of lipoxygenase and cytochrome P450 32 ) had no significant effect on the transient contractile response to hypoxia in endothelium-intact or denuded vessels, suggesting that this response does not involve an eicosanoid. While one might have expected that the observed relaxation on return to normoxia might be due to the removal of hypoxiainduced inhibition of EDRF production, reduction of the magnitude of this response in endotheliumdenuded rings was not statistically significant, and the inhibitors of EDRF did not prevent the transient vasodilation. Thus, the mechanism of the nonendothelium-dependent component of hypoxiainduced vasoconstriction, and the transient vasodilation observed on return to normoxia are not known.
Two potential components of the additional hypoxia-induced contraction, which were not addressed in the current experiments, are noneicosanoid endothelium-independent factors and non-EDRF endothelium-dependent factors. For example, the non-EDRF component could be due to the release of an endothelium-derived constricting factor as demonstrated by Rubanyi and Vanhoutte 34 in canine coronary arteries using bioassay (sandwich) experiments. In contrast to the rabbit pulmonary artery, release of an endothelium-derived constricting factor appears to be the primary mechanism of hypoxia-induced constriction of canine coronary and femoral arteries as inhibitors of EDRF (methylene blue, quinacrine, and phenidone) had no effect on the hypoxic contraction in those vessels. 34 This may be due to differences in species (rabbit vs. dog) or of blood vessels studied (pulmonary vs. coronary artery). A POi of 40±10 mm Hg appears to be the threshold for inhibition of EDRF production in this isolated large pulmonary artery model. Oxygen tensions of 50 mm Hg or greater did not produce consistent inhibition, and P<*2 values of 30 mm Hg or less caused irreversible changes in vascular ring reactivity.
Several other investigators have found endotheliumdependent vasodilation to be sensitive to oxygen tension. There appears to be an optimal PO; for endothelium-dependent responses in systemic muscular arteries. DeMey and Vanhoutte 17 obtained maximal endothelium-dependent relaxations to acetyicholine at a PO2 of 145 mm Hg. Both higher (650 mm Hg) and lower (22, 5 , and 0 mm Hg) oxygen tensions reduced the relaxation. In another study, 18 these investigators found that removal of the endothelium from isolated dog femoral arteries reduced the anoxic augmentation of contractile responses to noradrenaline, potassium chloride, and BaCl 2 . Indomethacin did not affect these responses. Singer et al, 33 studying rabbit thoracic aorta rings, found that endotheliumintact rings constricted transiently to hypoxia (P02 of 30 mm Hg) while denuded rings relaxed. Rubanyi and Vanhoutte 34 have shown endothelium-dependent constriction in coronary arteries in response to hypoxia that was not prevented by inhibitors of cyclooxygenase, lipoxygenase, or phospholipase A 2 or of adrenergic, serotonegric, or nistaminergic receptors. Unlike the present experiments, in many of these studies, adequate controls were not performed to demonstrate that the vessels were not functionally damaged by exposure to anoxia/hypoxia. Endothelium-dependent, hypoxia-induced constriction of pulmonary arteries also has been observed. Holden and McCall 35 studied hypoxia preadapted (PO2 of 40 mm Hgx4-6 hours) porcine pulmonary artery strips with and without endothelium. When the Po? of these preadapted vessels was subsequently decreased from 140 to 40 to 0 mm Hg, progressive contraction was observed that was markedly greater in strips with intact endothelium. Unlike the current studies, these vessels were not precontracted with phenylephrine, and an extensive hypoxic preadaptation period was required to elicit the contractile response. Pretreatment with indomethacin, atropine, phentolamtne, or propranolol had no effect on this response. These results would be consistent with hypoxia-induced inhibition of EDRF release or action or the hypoxia-induced release of an endothelium-derived vasoconstrictor. The former hypothesis is favored by the fact that these investigators could not demonstrate release or transfer of a constricting factor in sandwich experiments in which a vascular strip with intact endothelium was placed against an endotheliumdenuded strip mounted for tension measurement. The present study clearly demonstrates that endothelium-dependent relaxations can be selectively inhibited in the pulmonary artery by a PO2 of 40 mm Hg and thus offers a possible explanation of the results obtained by Holden and McCall. 35 It is not possible to directly extrapolate these data obtained in isolated, large first-branch pulmonary arteries to the in vivo process of hypoxic pulmonary vasoconstriction. This physiological response is primarily due to constriction of small (<300 fim) pulmonary arterioles. 36 If, however, endotheliumdependent relaxation in these small vessels is also inhibited by hypoxia, it is possible that hypoxiainduced inhibition of EDRF release plays a role in eliciting or modulating the hypoxic pulmonary vasoconstriction response. Ignarro et al, 37 have shown that endothelium-dependent relaxation and cyclic GMP accumulation per milligram protein is inversely proportional to the size of branches of bovine pulmonary artery. This would be consistent with an important role for EDRF in modulation of small pulmonary vessel tone. Madden et al 38 have demonstrated a decreased contractile response to hypoxia in endothelium-damaged, 300 -jim isolated cat pulmonary arteries; however, the functional status of the vascular smooth muscle was not clearly documented. Thus, while EDRF may play a significant role in smaller pulmonary vessels, definitive evidence of a physiological role for EDRF in the pulmonary microcirculation has not yet been proven.
In summary, moderate hypoxia impairs endotheliumdependent vasodilation of rabbit pulmonary arteries but does not affect the relaxation due to endotheliumindependent dilators. Hypoxia also inhibits basal EDRF production or release in these vessels, which accounts for part of the contractile response seen after exposure to hypoxia. The site at which hypoxia exerts its effect appears to be distal to receptor activation at the endothelial cell and proximal to guanylate cyclase activation in vascular smooth muscle.
